Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model.

BACKGROUND: IL-13 receptor (IL-13R) targeted cytotoxin, IL13-PE38QQR, has been shown to have very potent anti-tumor activity to IL-13R-expressing head and neck tumor cells in vitro and in vivo. However, its effect is limited in aggressive tumors. To further improve the anti-tumor activity and safety...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kawakami, Koji, Husain, Syed R., Kawakami, Mariko, Puri, Raj K.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2002
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2040009/
https://ncbi.nlm.nih.gov/pubmed/12435859
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים